M. Kulyk & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.14M | Buy |
90,244
+15,583
| +21% | +$1.23M | 1.55% | 21 |
|
|
2025
Q1 | $6.7M | Buy |
74,661
+6,216
| +9% | +$558K | 1.53% | 22 |
|
|
2024
Q4 | $6.81M | Buy |
68,445
+3,573
| +6% | +$355K | 1.47% | 23 |
|
|
2024
Q3 | $7.37M | Buy |
64,872
+2,096
| +3% | +$238K | 1.48% | 24 |
|
|
2024
Q2 | $7.77M | Buy |
62,776
+394
| +0.6% | +$48.8K | 1.81% | 16 |
|
|
2024
Q1 | $8.23M | Buy |
62,382
+1,534
| +3% | +$202K | 1.91% | 15 |
|
|
2023
Q4 | $6.63M | Buy |
60,848
+3,720
| +7% | +$406K | 1.55% | 24 |
|
|
2023
Q3 | $5.88M | Buy |
57,128
+9,080
| +19% | +$935K | 1.63% | 20 |
|
|
2023
Q2 | $5.54M | Sell |
48,048
-1,646
| -3% | -$190K | 1.55% | 24 |
|
|
2023
Q1 | $5.29M | Buy |
49,694
+2,211
| +5% | +$235K | 1.6% | 25 |
|
|
2022
Q4 | $5.27M | Buy |
47,483
+925
| +2% | +$103K | 1.76% | 22 |
|
|
2022
Q3 | $4.01M | Buy |
+46,558
| New | +$4.01M | 1.39% | 26 |
|
|
2022
Q2 | – | Sell |
-3,100
| Closed | -$254K | – | 102 |
|
|
2022
Q1 | $254K | Sell |
3,100
-1,390
| -31% | -$114K | 0.07% | 92 |
|
|
2021
Q4 | $344K | Buy |
4,490
+1,400
| +45% | +$107K | 0.09% | 70 |
|
|
2021
Q3 | $232K | Buy |
3,090
+359
| +13% | +$27K | 0.07% | 66 |
|
|
2021
Q2 | $212K | Sell |
2,731
-131
| -5% | -$10.2K | 0.08% | 62 |
|
|
2021
Q1 | $211K | Sell |
2,862
-103
| -3% | -$7.59K | 0.08% | 72 |
|
|
2020
Q4 | $231K | Buy |
+2,965
| New | +$231K | 0.13% | 49 |
|